Results (3754)
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting

Investigation of risk of rare eye condition with semaglutide medicines

114 new medicines recommended for approval; 46 had a new active substance

Updated policies for committee members, experts and Management Board members effective from May 2025

Enhanced EU collaboration to allow faster and wider access to innovative health technologies

EMA and HMA update principles for identification and disclosure of commercially confidential information and personal data
EMA's Executive Director shares her end-of-year message and takes stock of EMA's work in 2024
The European Medicines Agency's (EMA) office is closed from 18:00 on 19 December 2024 to 08:30 on 6 January 2025

Report outlines recommendations and next steps

Work programme and budget for 2025 among other topics